- Home
- SCCO vs BMY Comparison
SCCO vs BMY Comparison
Compare SCCO & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCCO
- BMY
- Stock Information
- Founded
- SCCO 1952
- BMY 1887
- Country
- SCCO United States
- BMY United States
- Employees
- SCCO N/A
- BMY N/A
- Industry
- SCCO Metal Mining
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- SCCO Basic Materials
- BMY Health Care
- Exchange
- SCCO Nasdaq
- BMY Nasdaq
- Market Cap
- SCCO 82.0B
- BMY 94.0B
- IPO Year
- SCCO N/A
- BMY N/A
- Fundamental
- Price
- SCCO $132.08
- BMY $43.65
- Analyst Decision
- SCCO Hold
- BMY Hold
- Analyst Count
- SCCO 7
- BMY 14
- Target Price
- SCCO $112.76
- BMY $57.54
- AVG Volume (30 Days)
- SCCO 2.2M
- BMY 19.2M
- Earning Date
- SCCO 10-24-2025
- BMY 10-30-2025
- Dividend Yield
- SCCO 2.40%
- BMY 5.69%
- EPS Growth
- SCCO 31.70
- BMY N/A
- EPS
- SCCO 4.48
- BMY 2.49
- Revenue
- SCCO $11,888,200,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- SCCO $8.26
- BMY N/A
- Revenue Next Year
- SCCO N/A
- BMY N/A
- P/E Ratio
- SCCO $29.44
- BMY $17.54
- Revenue Growth
- SCCO 13.01
- BMY 2.57
- 52 Week Low
- SCCO $73.44
- BMY $42.96
- 52 Week High
- SCCO $136.50
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- SCCO 66.99
- BMY 38.58
- Support Level
- SCCO $127.51
- BMY $43.27
- Resistance Level
- SCCO $134.06
- BMY $45.19
- Average True Range (ATR)
- SCCO 3.83
- BMY 1.13
- MACD
- SCCO 0.15
- BMY -0.08
- Stochastic Oscillator
- SCCO 77.40
- BMY 7.41
About SCCO Southern Copper Corporation
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.